StemRIM Inc.’s overnight PTS trading price was ¥358, up 0.28% from the Tokyo Stock Exchange closing price. The next earnings announcement is scheduled for 9 September 2026, and the earnings report summary indicates progress in the development of regenerative medicine-inducing drugs and the company’s financial position.
According to StemRIM Inc.’s share price information, the overnight PTS trading price was ¥358 (as of 23:54), up ¥1, or 0.28%, from the Tokyo Stock Exchange closing price. The opening price was ¥357, the high was ¥358, the low was ¥357, trading volume was 1,700 shares and trading value was ¥607,000.
In earnings-related information, the next earnings announcement is scheduled for 9 September 2026. The earnings report summary states that, in the third quarter of the fiscal year ending July 2026, the company focused on developing regenerative medicine-inducing drugs and recorded an operating loss of ¥1.484 billion and an ordinary loss of ¥1.437 billion. R&D expenses were ¥1.119 billion, up 3.9% year on year, and funding for R&D activities has been secured through 2028.
As stock indicators, the market capitalization is approximately ¥22,377 million, shares outstanding total 62,681,200, the actual PBR is 4.86x, the year-to-date high is ¥368 and the year-to-date low is ¥260. The minimum purchase amount is ¥35,700, and the trading unit is 100 shares.
The explanation of overnight PTS trading and related information states that overnight trading is conducted on J-Market, operated by Japan Next Securities, and that overnight trading takes place on business days, as in the Tokyo market.